A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults

被引:11
作者
Cooper, Curtis [1 ]
Hutton, Brian [1 ]
Fergusso, Dean [1 ]
Mills, Edward [2 ]
Klein, Marina B. [3 ]
Boivin, Guy [4 ]
Halperin, Scott [5 ]
机构
[1] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa Gen Hosp, Div Infect Dis,Methods Ctr, Ottawa, ON K1H 8L6, Canada
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] McGill Univ, Montreal, PQ, Canada
[4] Univ Laval, Laval, PQ, Canada
[5] Dalhousie Univ, Halifax, NS, Canada
关键词
HIV; Immunocompromised; Influenza; Vaccine;
D O I
10.1155/2008/419710
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BACKGROUND: HIV-seropositive adults are at an increased risk for influenza infection. They also develop more severe influenza disease and are hyporesponsive to current influenza vaccinations. METHODS: The authors examined findings from a systematic review of influenza vaccination in HIV-seropositive adults, and evaluated other relevant Studies. A narrative overview of findings formulated to summarize the implications Of Currently available literature is presented. The primary goal of the present review is to assess the limitations of current evidence and to provide I framework for additional research. RESULTS: There is a paucity of knowledge regarding the relative value of prophylactic influenza vaccination in HIV-positive adults compared with immunocompetent populations. There are shortcomings related to study methodology and temporal changes in the characteristics of patient baseline immune status, which limit the utility Of this information to Shape public health policy. CONCLUSIONS: There is I pressing need to pursue methodologically rigorous Studies that Will increase knowledge related to improving the effectiveness of preventive influenza measures in this patient population.
引用
收藏
页码:419 / 423
页数:5
相关论文
共 31 条
[21]  
Roos-van Eijndhoven DG, 2001, J MED VIROL, V63, P293, DOI 10.1002/1096-9071(200104)63:4&lt
[22]  
293::AID-JMV1004&gt
[23]  
3.0.CO
[24]  
2-C
[25]   INFLUENZA IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
SAFRIN, S ;
RUSH, JD ;
MILLS, J .
CHEST, 1990, 98 (01) :33-37
[26]   ACTIVATION OF VIRUS-REPLICATION AFTER VACCINATION OF HIV-1-INFECTED INDIVIDUALS [J].
STAPRANS, SI ;
HAMILTON, BL ;
FOLLANSBEE, SE ;
ELBEIK, T ;
BARBOSA, P ;
GRANT, RM ;
FEINBERG, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1727-1737
[27]   Efficacy of influenza vaccination in HIV-infected persons - A randomized, double-blind, placebo-controlled trial [J].
Tasker, SA ;
Treanor, JJ ;
Paxton, WB ;
Wallace, MR .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (06) :430-433
[28]   Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine [J].
Treanor, JJ ;
Campbell, JD ;
Zangwill, KM ;
Rowe, T ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) :1343-1351
[29]  
Yamanaka H, 2005, JAIDS-J ACQ IMM DEF, V39, P167
[30]   Safety and immunogenicity of influenza vaccination in individuals infected with HIV [J].
Zanetti, AR ;
Amendola, A ;
Besana, S ;
Boschini, A ;
Tanzi, E .
VACCINE, 2002, 20 :B29-B32